Early Detection of COPD to Prevent Cardiovascular Deterioration via Multimodal Digital Monitoring (C-COPE)
| Reference number | |
| Coordinator | GattyInstruments AB |
| Funding from Vinnova | SEK 494 594 |
| Project duration | December 2025 - May 2026 |
| Status | Completed |
| Venture | Global cooperation 2025 |
| Call | Planning grant for international proposal 2025 |
Important results from the project
The project goals were largely achieved through successful grant preparation, partner discussions, and consolidation of the project structure and objectives for the main application. The project improved understanding of clinical study requirements and budget prioritization, reducing uncertainties for future implementation. In addition, collaborations and networks within healthcare and industry were strengthened, while new opportunities for product applications and partnerships were identified.
Expected long term effects
Long-term, C-COPE shifts COPD-CVD management from reactive to proactive outpatient monitoring. Early detection prevents severe cardiovascular deterioration, reducing hospitalizations and increasing healthy life years. It delivers substantial healthcare savings and provides a scalable digital health model for other chronic diseases.
Approach and implementation
Led by GattyInstruments, C-COPE was structured across five interdisciplinary work packages spanning Sweden, France, and Türkiye. The implementation integrated mature technologies like Spiroluft and BORA Care into a secure federated platform. Rather than basic research, the project focused on co-designing and validating a real-world, nurse-led "alert-to-action" clinical pilot for 120 patients.